Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Cardiovascular Diabetology|February 21, 2018
Report from the 3rd Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes & Cardiovascular Disease (D&CVD) EASD Study GroupOliver Schnell, Eberhard Standl, Doina Catrinoiu, et al.
Cardiovascular Diabetology|March 13, 2019
Report from the 4th Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes & Cardiovascular Disease (D&CVD) EASD Study GroupOliver Schnell, Eberhard Standl, Doina Catrinoiu, et al.
International Journal of Cardiology|September 26, 2015
Mineralocorticoid receptor antagonists, a class beyond spironolactone--Focus on the special pharmacologic properties of eplerenonePetar M Seferovic, Francesco Pelliccia, Ivana Zivkovic, et al.
Diabetologia|December 18, 2025
Impact of overweight and obesity on fasting insulin secretion in men and women without diabetes: effect sizes and mechanismsMartina Chiriacò, Domenico Tricò, John R Petrie, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|January 6, 2020
Insulin Therapy in Adults with Type 1 Diabetes Mellitus: a Narrative ReviewAndrej Janež, Cristian Guja, Asimina Mitrakou, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|March 15, 2021
Expert Opinion: A Call for Basal Insulin Titration in Patients with Type 2 Diabetes in Daily Practice: Southeast European PerspectiveNicolae Hancu, Andrej Janez, Nebojsa Lalic, et al.
Herz|January 22, 2010
Stenting and surgery for coronary vasospasm : the wrong solution fails to solve the problemMilan A Nedeljkovic, Miodrag Ostojic, Nebojsa Lalic, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|October 23, 2024
Unveiling the Spectrum of Glucose Variability: A Novel Perspective on FreeStyle Libre Monitoring DataAdrian H Heald, Mike Stedman, John Warner-Levy, et al.
Diabetes Care|June 29, 2021
Advancing Therapy in Suboptimally Controlled Basal Insulin-Treated Type 2 Diabetes: Clinical Outcomes With iGlarLixi Versus Premix BIAsp 30 in the SoliMix Randomized Controlled TrialJulio Rosenstock, Rifat Emral, Leobardo Sauque-Reyna, et al.
Acta Diabetologica|April 25, 2016
Prevalence and risk factors for prolonged QT interval and QT dispersion in patients with type 2 diabetesVladan M Ninkovic, Srdjan M Ninkovic, Vanja Miloradovic, et al.
Pageof 5